Cargando…
Usefulness of Two Independent DNA and RNA Tissue-Based Multiplex Assays for the Routine Care of Advanced NSCLC Patients
Personalized medicine is nowadays a paradigm in lung cancer management, offering important benefits to patients. This study aimed to test the feasibility and utility of embedding two multiplexed genomic platforms as the routine workup of advanced non-squamous non-small cell lung cancer (NSCLC) patie...
Autores principales: | Marin, Elba, Teixido, Cristina, Carmona-Rocha, Elena, Reyes, Roxana, Arcocha, Ainara, Viñolas, Nuria, Rodríguez-Mues, MªCarmen, Cabrera, Carlos, Sánchez, Marcelo, Vollmer, Ivan, Castillo, Sergi, Muñoz, Silvia, Sullivan, Ivana G., Rodriguez, Adela, Garcia, Mireia, Alos, Silvia, Jares, Pedro, Martinez, Antonio, Prat, Aleix, Molina-Vila, Miguel Ángel, Reguart, Noemi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281583/ https://www.ncbi.nlm.nih.gov/pubmed/32365867 http://dx.doi.org/10.3390/cancers12051124 |
Ejemplares similares
-
A Pilot Study to Evaluate Early Predictive Value of Thorax Perfusion-CT in Advanced NSCLC
por: Aya, Francisco, et al.
Publicado: (2021) -
Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer Patients
por: Marin, Elba, et al.
Publicado: (2020) -
182P Impact of SARS CoV 2 outbreak in the molecular diagnosis of advanced NSCLC: A retrospective comparative cohort study
por: Marin, E., et al.
Publicado: (2021) -
Multiplex RNA‐based detection of clinically relevant MET alterations in advanced non‐small cell lung cancer
por: Aguado, Cristina, et al.
Publicado: (2020) -
Technical Evaluation of the COBAS EGFR Semiquantitative Index (SQI) for Plasma cfDNA Testing in NSCLC Patients with EGFR Exon 19 Deletions
por: González de Aledo-Castillo, José Manuel, et al.
Publicado: (2021)